Pan-Cancer Analysis of BST2 Expression, Prognostic Significance, and Immune Correlations
Abstract Objective: This study aimed to investigate the expression of the bone marrow stromal cell antigen 2 (BST2) gene in malignant tumors originating from various tissues and to explore its clinical significance. Methods: We employed the TCGA database, R software, GeneMANIA database, and biological information analysis technologies to analyze the expression of the BST2 gene across various tumor tissues at different pathological stages and to assess its association with tumor prognosis, mutations, immune invasion, immune checkpoint-related genes, and associated pathways.
This article is available to registered members
Create a free account to access our full library of peer-reviewed research on medical cannabis.
Join — it's freeAlready a member? Log in